Word

T2D

Status

Dead

Status Code

602

Status Date

Tuesday, January 3, 2017

Serial Number

86696547

Mark Type

5000

Filing Date

Friday, July 17, 2015

Abandoned Date

Monday, November 28, 2016

Trademark Owner History

Intarcia Therapeutics, Inc.

Classifications

5 Pharmaceutical preparations for the treatment of obesity and metabolic diseases/disorders

10 Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of obesity and metabolic diseases/disorders

41 Development and dissemination of educational materials of others in the fields of obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith

42 Research and development of pharmaceutical preparations, products and technology in the fields of obesity and metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; medical and scientific research in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals

44 Medical information services, namely, providing information on the topics of obesity and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, drug delivery technologies, and administration of pharmaceuticals

Color is not claimed as a feature of the mark.
The mark consists of capitalized three-dimensional letters T2D.
T TWO D

Trademark Events

Jan 4, 2017

Abandonment Notice Mailed - Failure To Respond

Jan 3, 2017

Abandonment - Failure To Respond Or Late Response

May 24, 2016

Notification Of Final Refusal Emailed

May 24, 2016

Final Refusal E-Mailed

May 24, 2016

Final Refusal Written

May 3, 2016

Teas/Email Correspondence Entered

May 2, 2016

Correspondence Received In Law Office

May 2, 2016

Teas Response To Office Action Received

Nov 3, 2015

Notification Of Non-Final Action E-Mailed

Nov 3, 2015

Non-Final Action E-Mailed

Nov 3, 2015

Non-Final Action Written

Oct 28, 2015

Assigned To Examiner

Jul 24, 2015

Notice Of Pseudo Mark E-Mailed

Jul 23, 2015

New Application Office Supplied Data Entered In Tram

Jul 20, 2015

New Application Entered In Tram